COYA
Price:
$4.74
Market Cap:
$86.31M
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at tr...[Read more]
Industry
Biotechnology
IPO Date
2022-12-29
Stock Exchange
NASDAQ
Ticker
COYA
According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.58M. This represents a change of -28.50% compared to the average of 49.77M of the last 4 quarters.
The mean historical Enterprise Value of Coya Therapeutics, Inc. over the last ten years is 37.50M. The current 35.58M Enterprise Value has changed 9.39% with respect to the historical average. Over the past ten years (40 quarters), COYA's Enterprise Value was at its highest in in the March 2024 quarter at 105.70M. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.
Average
37.50M
Median
45.83M
Minimum
3.12M
Maximum
54.17M
Discovering the peaks and valleys of Coya Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 729.28%
Maximum Annual Enterprise Value = 54.17M
Minimum Annual Increase = -21.19%
Minimum Annual Enterprise Value = 3.12M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 50.21M | 2.52% |
| 2024 | 48.98M | 14.74% |
| 2023 | 42.69M | -21.19% |
| 2022 | 54.17M | 109.65% |
| 2021 | 25.84M | 729.28% |
The current Enterprise Value of Coya Therapeutics, Inc. (COYA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
47.29M
5-year avg
44.38M
10-year avg
37.50M
Coya Therapeutics, Inc.’s Enterprise Value is less than Immix Biopharma, Inc. (381.48M), less than Clene Inc. (76.31M), less than MacroGenics, Inc. (221.70M), less than Oramed Pharmaceuticals Inc. (145.94M), less than Ovid Therapeutics Inc. (210.73M), less than Context Therapeutics Inc. (73.47M), less than Pliant Therapeutics, Inc. (76.56M), less than Whitehawk Therapeutics Inc (170.93M), less than Shattuck Labs, Inc. (148.26M), less than Zentalis Pharmaceuticals, Inc. (269.67M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 381.48M | $459.70M | |
| 76.31M | $60.20M | |
| 221.70M | $251.71M | |
| 145.94M | $158.38M | |
| 210.73M | $303.33M | |
| 73.47M | $127.71M | |
| 76.56M | $69.97M | |
| 170.93M | $205.72M | |
| 148.26M | $236.64M | |
| 269.67M | $266.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Coya Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Coya Therapeutics, Inc. (COYA)?
What is the 3-year average Enterprise Value for Coya Therapeutics, Inc. (COYA)?
What is the 5-year average Enterprise Value for Coya Therapeutics, Inc. (COYA)?
How does the current Enterprise Value for Coya Therapeutics, Inc. (COYA) compare to its historical average?